Pfizer, AstraZeneca COVID-19 Vaccines Effective Against Indian Variant: Study
Study shows that after two doses, the Pfizer vaccine is 88 percent effective in protecting against symptomatic disease from the variant
U.S. COVID-19 Infections, Deaths Drop to Levels Not Seen Since Last Summer
United States reporting about 25,700 new COVID-19 cases daily, a 39 percent decrease from two weeks ago
COVID-19 Symptom Exacerbation Leading Cause of Reencounters
Neurologic illness prior to COVID-19 a predictor for acute-care hospital reencounters within 30 days and four months
DDW: Irritable Bowel Syndrome Severity Symptoms Improved in Lockdown
Proportion of severe IBS patients and mean IBS Severity Scale decreased during lockdown versus prepandemic, may be secondary to reduction in external stress burdens
ACC: Fish Oil Does Not Improve Outcomes for Those at High CV Risk
Patients with the highest levels of EPA had similar rates of major adverse cardiovascular events as patients taking placebo
Ethnicity-Specific BMI Cutoffs for Obesity Needed to Assess T2DM Risk
BMI cutoffs equivalent to 30.0 kg/m2 in Whites were 23.9, 28.1, 26.9, and 26.6 kg/m2 for South Asian, Black, Chinese, Arab populations
Upadacitinib Treats Moderate-to-Severe Atopic Dermatitis
Two replicate double-blind, randomized, placebo-controlled trials show short-term efficacy for upadacitinib in adolescents and adults
Screening Endoscopy May Lower CRC-Related Mortality in Healthy Elderly
Risk for CRC-related mortality reduced with screening endoscopy for those older than 75 years who do not have significant comorbidities
Minority of Those With AUD Referred to, Receive Treatment
However, health care use and screening are common for alcohol use disorder
Neighborhood, Socioeconomic Factors Affect Heart Attack Survival
Findings seen during 11 years of follow-up among those having a heart attack at age 50 years or younger
